SCHEMBL697888

SCHEMBL697888

CCOc1ccc(CO)cc1OCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.61
S1PR1 P21453 4/20 0.54
S1PR3 Q99500 3/20 0.54
ALDH1A1 P00352 4/20 0.49
LMNA P02545 3/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C9 P11712 2/20 0.49
MAPT P10636 2/20 0.49
CYP2C19 P33261 1/20 0.49
CALM1 P0DP23 3/20 0.49
F2 P00734 1/20 0.48
F10 P00742 1/20 0.48
PRSS1 P07477 1/20 0.48
F7 P08709 1/20 0.48
MAPK1 P28482 3/20 0.47
POLB P06746 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP3A4 P08684 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL579760 0.90 CALM1 (0.61) HTTS1PR1S1PR3LMNAMAPT
SCHEMBL30714383 0.90 CALM1 (0.61) HTTS1PR1S1PR3LMNAMAPT
SCHEMBL3972900 0.90 L3MBTL1 (0.54) HTTALDH1A1MAPTCALM1MAPK1
SCHEMBL11470313 0.88 HTT (0.52) HTTS1PR1S1PR3ALDH1A1LMNA
SCHEMBL6035606 0.87 MEN1 (0.60) HTTALDH1A1LMNAMAPTCALM1
SCHEMBL16953715 0.86 HTT (0.50) HTTS1PR1S1PR3ALDH1A1LMNA
SCHEMBL7216797 0.85 HTT (0.50) HTTS1PR1S1PR3ALDH1A1LMNA
SCHEMBL28515521 0.84 HTT (0.49) HTTS1PR1S1PR3ALDH1A1LMNA
SCHEMBL16951979 0.84 HTT (0.49) HTTS1PR1S1PR3ALDH1A1LMNA
SCHEMBL13413506 0.84 POLB (0.49) HTTS1PR1S1PR3ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101258119-B Process for preparing 3, 4-dioxo-substituted aromatic aldehydes ENDURA SPA 2014-06-18 CN claimed
EP-1910260-B1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES ENDURA SPA (IT) 2009-12-16 EP claimed
US-7544843-B2 Process for preparing 3,4-dioxo-substituted aromatic aldehydes ENDURA S.P.A. (IT) 2009-06-09 US claimed
US-20090062569-A1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES ENDURA S.P.A. (IT) 2009-03-05 US claimed
CN-101258119-A Process for preparing 3, 4-dioxo-substituted aromatic aldehydes ENDURA SPA (IT) 2008-09-03 CN claimed
EP-1910260-A1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES ENDURA S.p.A. (IT) 2008-04-16 EP claimed
WO-2007012641-A1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES ENDURA S.P.A. (IT) 2007-02-01 WO claimed
US-11840508-B2 Catalyst system for olefin polymerization and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2023-12-12 US disclosed
CN-112300303-B Catalyst system for olefin polymerization and application thereof 中国石油化工股份有限公司 2023-08-15 CN disclosed
CN-112300304-B Catalyst system for olefin polymerization and prepolymerized catalyst composition 中国石油化工股份有限公司 2023-08-15 CN disclosed
CN-112300302-B Twelve-membered ring compound and application thereof 中国石油化工股份有限公司 2023-05-09 CN disclosed
US-20220251016-A1 CATALYST SYSTEM FOR OLEFIN POLYMERIZATION AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2022-08-11 US disclosed
EP-4006061-A1 CATALYST SYSTEM FOR OLEFIN POLYMERIZATION AND USE THEREOF China Petroleum & Chemical Corporation (CN) 2022-06-01 EP disclosed
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 EP disclosed
US-5149884-A Oxidative dehydrogenation of aromatic or aliphatic alcohols in gas phase BASF AKTIENGESELLSCHAFT (DE) 1992-09-22 US disclosed
EP-0244632-B1 TUBE BUNDLE REACTOR, ITS USE IN EXOTHERMAL ORGANIC REACTIONS AND PROCESS FOR THE PREPARATION OF KETONES AND ALDEHYDES BASF Aktiengesellschaft (DE) 1991-02-20 EP disclosed
EP-0244632-A2 Tube bundle reactor, its use in exothermal organic reactions and process for the preparation of ketones and aldehydes BASF Aktiengesellschaft (DE) 1987-11-11 EP disclosed
US-4224254-A OXIDATION OF AROMATIC ALCOHOLS, SILVER CATALYST BASF AKTIENGESELLSCHAFT (DE) 1980-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11840508-B2 Catalyst system for olefin polymerization and use thereof SQSTM1, SAMM50, HPD HTT 2726/4885S1PR1 3865/4885S1PR3 3864/4885
US-20090062569-A1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES HAAO, AOX1, ADH1A HTT 1989/4885S1PR1 1791/4885S1PR3 1386/4885
US-20220251016-A1 CATALYST SYSTEM FOR OLEFIN POLYMERIZATION AND USE THEREOF SQSTM1, SAMM50, HPD HTT 2726/4885S1PR1 3865/4885S1PR3 3864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.